Interés Humano

Vacuna de Johnson & Johnson ‘aumenta riesgo’ de rara enfermedad del sistema nervioso

FDA identificó 100 casos de un raro trastorno neurológico tras la inyección de 12,5 millones de dosis

(FILES) In this file photo taken on March 4, 2021 Home base primary care Pharmacist Erin Emonds logs onto a computer before filling syringes the Johnson & Johnson Janssen vaccine at the US Department of Veterans Affairs' VA Boston Healthcare System's Jamaica Plain Medical Center in Boston, Massachusetts. - The United States should resume Johnson & Johnson Covid-19 vaccinations, an expert panel recommended to health authorities on April 23, after a pause prompted by blood clot concerns.
"The Janssen Covid-19 vaccine is recommended for persons 18 years of age and older in the US population under the FDA, emergency use authorization," the group covened by the Centers for Disease Control and Prevention said. (Photo by Joseph Prezioso / AFP)
(FILES) In this file photo taken on March 4, 2021 Home base primary care Pharmacist Erin Emonds logs onto a computer before filling syringes the Johnson & Johnson Janssen vaccine at the US Department of Veterans Affairs' VA Boston Healthcare System's Jamaica Plain Medical Center in Boston, Massachusetts. - The United States should resume Johnson & Johnson Covid-19 vaccinations, an expert panel recommended to health authorities on April 23, after a pause prompted by blood clot concerns. "The Janssen Covid-19 vaccine is recommended for persons 18 years of age and older in the US population under the FDA, emergency use authorization," the group covened by the Centers for Disease Control and Prevention said. (Photo by Joseph Prezioso / AFP) JOSEPH PREZIOSO
‌
‌

‌

‌
‌

‌

‌